Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World February 25, 2015 Rebecca Trager	US opens up home DNA screening The US Food and Drug Administration has, for the first time, authorized a genetic test to be sold directly to consumers. The agency plans to ease the regulatory path for similar screening tests.
Popular Mechanics January 2010 Amber Angelle	How to Create a Designer Baby Women undergoing in vitro fertilization could one day choose to have a baby boy with perfect vision, an aptitude for sports and a virtual lock on avoiding colon cancer.
Fast Company Elizabeth Segran	23andMe And The FDA Reached A Pivotal Genetic Testing Agreement An FDA decision summary allows DNA-testing company 23andMe to market a genome test that screens for Bloom syndrome, a rare disorder that may lead toward the development of cancer.
Managed Care May 2005 Martin Sipkoff	Predictive Modeling & Genomics: Marriage of Promise and Risk Integration of predictive modeling and genomic tools means improved technology, enhanced databases, and appropriate legal guidance.
Fast Company David Lumb	The FDA Just OK'd 23AndMe To Test For One Syndrome The FDA just gave consumer genetics testing company 23AndMe permission to sell tests for Bloom syndrome -- a disease associated with shortened height and an increased cancer risk.
Managed Care November 2006 Maureen Glabman	Genetic Testing: Major Opportunity, Major Problems Whether a person is likely to develop diabetes, cancer, schizophrenia, or stroke will be reasonably well predicted, and tests can also determine whether a patient will respond to a given therapy. That's the good part.
HHMI Bulletin May 2012 Sarah C. P. Williams	Stephen Quake: Innovative Thinking on Genetic Tests His ideas have already led to a blood test to tell a pregnant woman whether her fetus has Down syndrome. Now, the HHMI investigator is pushing further, to track the success of heart transplants and diagnose autoimmune diseases and allergies.
Managed Care May 2001 Michael D. Dalzell	Powerful Opportunities For Good and Greed Genetic advances could spawn incredible improvements in health care. Given public demand, they also pose what may be unmanageable issues of resource use...
The Motley Fool May 28, 2010 Brian Orelli	Is It Time to Make Money Investing in Genetic Testing? Easier said than done.
Nurse Practitioner February 2010 Andrews et al.	ARVC: Help prevent sudden death Arrhythmogenic right ventricular cardiomyopathy is a dangerous condition that can cause sudden death.
Fast Company November 2013 Elizabeth Murphy	Inside 23andMe founder Anne Wojcicki's $99 DNA Revolution If Wojcicki gets it right, 23andMe could help change the health care industry as we know it. "At $99, we are opening the doors of access," she says. "Genetics is part of an entire path for how you're going to live a healthier life."
Managed Care April 2005 Michael Levin-Epstein	Time To Decipher Legislation's DNA Health plans have much at stake as Congress moves to lay down the do's and don'ts about use of info gathered via genetic testing.
Pharmaceutical Executive September 1, 2010	The Testing of the Tests FDA seeks to regulate genetic tests more actively, while encouraging diagnostic development.
Salon.com May 25, 2002 Katharine Mieszkowski	Our shiny happy clone future Procreation without sex, smarter babies and the right to choose the sexual orientation of your kids -- it's all good, says scientist Gregory Stock...
Fast Company David Lumb	Sites That Sell Cancer Gene Tests Don't Tell Customers The Whole Story, Study Finds Consumer tests that analyze DNA from tumors in order to help personalize a patient's treatment are in something of a Wild West period.
Fast Company November 2009 David H. Freedman	The Gene Bubble: Why We Still Aren't Disease-Free When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens.
Wired January 19, 2009 Brendan I. Koerner	DIY DNA: One Father's Attempt to Hack His Daughter's Genetic Code Nobody can say for sure what lies ahead for Beatrice, because no one really knows what's wrong with her.
Managed Care September 2002	Aetna Chief Wants Coverage For Genetic Tests The CEO of the country's largest for-profit HMO has jumped with both feet into the national discussion about genetic testing's place in health care.
IEEE Spectrum March 2013 Eliza Strickland	The Gene Machine and Me Ion Torrent's chip-based genome sequencer is cheap, fast, and poised to revolutionize medicine
The Motley Fool July 9, 2008 Brian Lawler	Predicting More Good News From Invitrogen Invitrogen gets a positive review from the FDA for one of its tests.
American Family Physician August 1, 2005 Wattendorf & Hadley	Family History: The Three-Generation Pedigree The three-generation pedigree provides a pictorial representation of diseases within a family and is the most efficient way to assess hereditary influences on disease.
Chemistry World July 2010 Anna Lewcock	Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition.
The Motley Fool February 4, 2010 Brian Orelli	Surfing the Wave of the Future: Personalized Medicine Medco buys in to personalized medicine. Yesterday Medco Health Solutions said it's purchasing genetic-testing expert DNA Direct.
Entrepreneur January 2006 Jacquelyn Lynn	The DNA Dilemma Should genetic discrimination be part of your employment practices liability insurance coverage?
Wired May 2002 Brian Alexander	The Remastered Race Artificial chromosomes and in vitro screening are giving new life to the eugenics debate. The question is not whether we want to engineer embryos but how far it should go...
Managed Care November 2006 Frank Diamond	Some Still Want To Know When There's Nothing to Be Done The use of genetic testing suggests that people will soon be able to know a lot - in some cases, an awful lot.
IndustryWeek February 17, 2010 Jonathan Katz	Rethinking Drug Testing For years it's been a no-brainer on the plant floor, but what do drug screens really tell us?
BusinessWeek November 7, 2005 Catherine Arnst	How Likely Are You To Get Sick? A new DNA database could gauge your risk for disease.
Chemistry World February 22, 2011 Amaya Camara-Campos	Repairing faulty genes Israeli scientists have developed compounds that could be better treatments for genetic diseases than current drugs.
Fast Company December 1, 2007 Amanda Bower	Are There Holes In My Genes? A new industry promises to gauge your genetic risk of getting diseases like cancer. Its investors, including John Doerr's Kleiner Perkins and Mark Kvamme's Sequoia Capital, have bet millions that consumers will buy it. Here, the author takes a test.
AskMen.com Jacob Franek	2008 Medical Science Developments Here are some 2008 medical science developments that might just yield the next big breakthrough.
HHMI Bulletin Nov 2010 Sarah C.P. Williams	Scientists Track Down Genetic Mutations In Record Time Scanning the human genome for a single disease-causing mutation is like taking a copy of War and Peace in a foreign language and searching for one misspelled word
Fast Company September 2000 John Ellis	The Secret of Life The mapping of the human genome, says Craig Venter, will change science, research, medicine, politics, health insurance, and the way biology looks at the last 3 billion years of evolution. And that's just the beginning.
Chemistry World March 23, 2015 Andrew Turley	23andMe jumps into drug R&D 23andMe plans to create a therapeutics group that will search for new leads using its database as a research platform.
American Journal of Nursing October 2009	Pharmacogenomics: Personalizing Drug Therapy Pharmacogenomics is a rapidly growing field of research into the ways in which genetic variation affects drug response.
Salon.com November 17, 1999 Kristi Coale	Playing God Scary eugenics documents from the turn of the century shine a disturbing light on ethical dilemmas raised by genetic testing.
The Motley Fool August 19, 2004 Charly Travers	Myriad's Making Hope Possible This small biotech provides screens that can help catch cancer. Even with solid growth of product revenue, losses could continue to increase as Myriad moves more drugs into clinical development while it transitions into a drug developer.
The Motley Fool January 4, 2005 Charly Travers	Cloning Fluffy Pet cloners like Genetic Savings & Clone (GSC) are clearly part of a new market on the verge of breaking open, and the opportunity for the first movers in this field is quite large. While private now, biotech investors need to keep watch.
Chemistry World June 6, 2007 Simon Hadlington	Large-Scale Gene Scanning for Common Diseases A multi-center genome scanning project that has analyzed half a million genetic markers in thousands of healthy people and people with a range of common diseases has revealed previously unknown genetic variants of the diseases.
AskMen.com Jacob Franek	Nutrigenomics 101 Nutrigenomics (also known as a DNA diet) attempts to marry nutrition with genetics, studying how our genes interact with food at the molecular level. But does it work?
Scientific American June 2009 Melinda Wenner	Genetic Copy Variations and Disease A new sense for how variable numbers of genes cause disease.
Pharmaceutical Executive June 1, 2011	To Screen or Not to Screen? What do our genetics tell us about our predisposition to certain diseases? What does this mean for pharmaceutical companies?
HHMI Bulletin February 2011	Crucibles of Dynamism Puzzling pockets of redundancy account for about 5 percent of the human genome. Investigator Evan Eichler found a way to interpret what is happening in these areas of genetic repetition.
Bio-IT World September 9, 2002 Kevin Davies	The Debate Over Race Relations Are self-identified labels of race useful in large-scale population genetic studies? A provocative commentary from a leading Stanford University geneticist has fuelled controversy.
Salon.com June 27, 2000 Ralph Brave	Building better humans The sci-fi possibilities of genetic tampering may soon become real. And there's no law against them.
Nurse Practitioner March 2009 Falkenstern & Bauer	Helping Kids Grow Interaction of genetic, nutritive, environmental, metabolic, and hormonal factors is necessary for normal growth and account for variability in the growth process.
Wired November 2002 David Ewing Duncan	DNA as Destiny DNA is the book of life. It's also the book of death. In the future we'll all be read cover to cover. Here's what it's like to take the world's first top-to-bottom gene scan.
The Motley Fool August 26, 2009 Brian Orelli	This One's Growing Through the Recession Sales at Myriad Genetics increased 40% in its recently completed second half of its fiscal year, even if that was a slowdown from the 55% increase in the first half.
The Motley Fool June 14, 2010 Bruce Bigelow	Genetic Testing Companies in San Diego, Boston, and San Francisco Studying FDA Letters The letters notify the companies that genome-sequencing tests they offer to consumers are medical devices that require the agency's approval.
Salon.com October 5, 2000 Leah Kohlenberg	Designer babies? Pediatrician and ethicist Joel Frader says that just because a family has had a child to provide a bone-marrow transplant for an ailing daughter, it doesn't mean custom-ordered kids are right around the corner...